YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2D325F284T
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,335
Award facts
- Contract value 100% obligated
- $2,335.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,335.28 to DMS Pharmaceutical Group Inc. for YF-VAX (Yellow Fever Vaccine) one-dose vials on August 4, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the prime contractor with no identified subcontractors on this award.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC, designated contract SPE2DR, carries a $500 million ceiling value and extends through December 31, 2036, positioning the company as a critical pharmaceutical supplier for Department of Defense healthcare operations worldwide. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to ensure reliable pharmaceutical supply chains for military medical facilities globally, with DMS Pharmaceutical Group's established performance across multiple product categories—including vaccines, oncology treatments, biologics, and specialty pharmaceuticals—demonstrating its capability to fulfill diverse and specialized DoD medical requirements.
Quick answers
Who was awarded contract SPE2D325F284T?
SPE2D325F284T was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 4, 2025.
How much is contract SPE2D325F284T worth?
The government has obligated $2,335 on SPE2D325F284T.
Is contract SPE2D325F284T an order under another contract?
Yes. SPE2D325F284T is a delivery order under SPE2D021DA002, an indefinite delivery contract.
Was contract SPE2D325F284T competed?
The extent of competition for SPE2D325F284T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award